Literature DB >> 22263078

Case series of treatment approaches in fit nonagenarians with stage IV non-small-cell lung cancer.

Gregory J Britt1, Elizabeth M Gaughan, Kim-Son H Nguyen, Jeremy L Warner, Michael A Goldstein, Mark S Huberman, Daniel B Costa.   

Abstract

An increasing number of nonagenarians are treated for non-small-cell lung cancer (NSCLC); however guidelines and case series describing the care of very elderly patients with advanced NSCLC are not available. Medical records of patients treated at Beth Israel Deaconess Medical Center between 2007 and 2009 who had NSCLC were reviewed, and those with stage IV NSCLC and age 90 or older were included in this case series. Three successive fit nonagenarians were identified out of the one hundred and one cases with stage IV NSCLC, and their clinical course was summarized. The first case depicts a conservative approach (best supportive care), while the later cases describe the use of platinum-based (carboplatin-pemetrexed) and anti-epidermal growth factor targeted therapies. This series illustrates the diversity of approaches now available and the evolving treatment paradigm as it applies to fit elderly with NSCLC, including nonagenarians. It also emphasizes the importance of considering performance status rather than biologic age when making treatment decisions.

Entities:  

Keywords:  EGFR; EGFR inhibitor; lung cancer; metastasis; mutation; non-small-cell lung cancer; nonagenarian

Year:  2011        PMID: 22263078      PMCID: PMC3256509          DOI: 10.3978/j.issn.2072-1439.2011.03.02

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  6 in total

Review 1.  Lung cancer in octogenarians.

Authors:  Elizabeth M Blanchard; Konstantinos Arnaoutakis; Paul J Hesketh
Journal:  J Thorac Oncol       Date:  2010-06       Impact factor: 15.609

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

Authors:  Makoto Maemondo; Akira Inoue; Kunihiko Kobayashi; Shunichi Sugawara; Satoshi Oizumi; Hiroshi Isobe; Akihiko Gemma; Masao Harada; Hirohisa Yoshizawa; Ichiro Kinoshita; Yuka Fujita; Shoji Okinaga; Haruto Hirano; Kozo Yoshimori; Toshiyuki Harada; Takashi Ogura; Masahiro Ando; Hitoshi Miyazawa; Tomoaki Tanaka; Yasuo Saijo; Koichi Hagiwara; Satoshi Morita; Toshihiro Nukiwa
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

4.  Cancer in nonagenarians: profile, treatments and outcomes.

Authors:  Martine Extermann; Edward J Crane; David Boulware
Journal:  Crit Rev Oncol Hematol       Date:  2010-08       Impact factor: 6.312

Review 5.  Treatment of advanced non-small-cell lung cancer in the elderly.

Authors:  Cesare Gridelli; Paolo Maione; Antonio Rossi; Marianna Luciana Ferrara; Vincenzo Castaldo; Giovanni Palazzolo; Nicole Mazzeo
Journal:  Lung Cancer       Date:  2009-10-29       Impact factor: 5.705

6.  American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.

Authors:  Christopher G Azzoli; Sherman Baker; Sarah Temin; William Pao; Timothy Aliff; Julie Brahmer; David H Johnson; Janessa L Laskin; Gregory Masters; Daniel Milton; Luke Nordquist; David G Pfister; Steven Piantadosi; Joan H Schiller; Reily Smith; Thomas J Smith; John R Strawn; David Trent; Giuseppe Giaccone
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.